Weekly CFDA News Roundup covers policies, regulations, QA/recall/AE, and new approvals in medical device and IVD in China. It is edited by China Med Device, LLC, a consulting firm specializing in China CFDA regulatory, CRO and market access services.
CFDA issued Interpretation of Clinical Trials Quality Control for Medical Devices. It requires that, to ensure consistency of clinical trial protocols in two-site clinical trials, a lead entity shall be defined, and the clinical trial shall be conducted in the same period of time.
CFDA issued 4 technical review guidelines, covering urology, gynecology and general devices.
CFDA announced recall notices to 14 medical devices from 7 foreign manufactures and 4 local ones. Foreign manufacturers include: